<?xml version="1.0" encoding="UTF-8"?>
<ref id="B18-ijerph-17-07588">
 <label>18.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Razmi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hashemi</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Gheytanchi</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Mashadi</surname>
    <given-names>M.D.</given-names>
   </name>
   <name>
    <surname>Ghods</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Madjd</surname>
    <given-names>Z.</given-names>
   </name>
  </person-group>
  <article-title>Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review</article-title>
  <source>Int. Immunopharmacol.</source>
  <year>2020</year>
  <volume>88</volume>
  <fpage>106942</fpage>
  <pub-id pub-id-type="doi">10.1016/j.intimp.2020.106942</pub-id>
  <?supplied-pmid 32896750?>
  <pub-id pub-id-type="pmid">32896750</pub-id>
 </element-citation>
</ref>
